Compare Trip.com Group Ltd (TCOM) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Trip.com Group Ltd vs Teladoc Health Inc — how do they compare? Trip.com Group Ltd trades at $39.37 (market cap $25.42B), while Teladoc Health Inc trades at $6.09 (market cap $1.11B). The key difference: Trip.com Group Ltd is far larger — about 22.9× Teladoc Health Inc's market cap, and Trip.com Group Ltd pays a 0.42% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| TCOM | TDOC | |
|---|---|---|
Market Cap | $25.42B | $1.11B |
Sector | Consumer Cyclical | Health |
52-Week High | $78.96 | $9.72 |
52-Week Low | $39.19 | $4.47 |
Enterprise Value | $18.03B | $1.37B |
Dividend Yield | 0.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Trip.com (TCOM) trades at $40.50, down 1.29% recently, with technical indicators showing a bearish short-term trend amid oversold RSI signals. The company reported strong 2025 revenue of $62.41B and net income of $33.29B, with high profitability margins, but faces headwinds from a recent $770M antitrust penalty in China (Reuters, 2026-07-24). Valuation ratios like P/E of 6.01 suggest potential undervaluation relative to earnings.
Outlook: Analyst consensus is bullish with a $59.29 price target (67% buy ratings), but near-term risks include regulatory scrutiny and mixed quarterly earnings. Long-term growth hinges on travel demand recovery and operational adjustments post-penalty.
TDOC trades at $6.26, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $200.32 million in 2025, though revenue remains stable at $2.53 billion. Analyst consensus is a hold with a $8.88 price target, while recent news highlights leadership changes and ongoing legal investigations.
The outlook is cautious; while valuation ratios like P/S of 0.45 and EV/EBITDA of 6.5 appear attractive, persistent losses and negative ROE of -12.99% pose risks. Upside depends on profitability improvements under new CFO Michael Grasher, but investor sentiment is tempered by weak earnings and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
